CAG
MGRX icon

Csenge Advisory Group’s Mangoceuticals MGRX Stock Holding History

Csenge Advisory Group’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6K Hold
10,000
– – ﹤0.01% 746
2025
Q4 		$7.4K Buy
+10,000
New +$16.2K ﹤0.01% 711

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $488M AUM 14.36% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

Csenge Advisory Group's MGRX Position: Q1 2026 in Review

Csenge Advisory Group held its Mangoceuticals (MGRX) position steady in Q1 2026 at 10,000 shares worth $3.6K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

Csenge Advisory Group first reported a position in MGRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.4K in Q4 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q1 2026.

  • Csenge Advisory Group held 10,000 shares of Mangoceuticals worth $3.6K as of Q1 2026.
  • Csenge Advisory Group left its Mangoceuticals share count unchanged in Q1 2026.
  • Mangoceuticals made up ﹤0.01% of Csenge Advisory Group's portfolio in Q1 2026, its #746 holding.
  • Csenge Advisory Group first reported a position in Mangoceuticals in Q4 2025 and has held it in 2 quarters since.
  • Csenge Advisory Group's Mangoceuticals position peaked at $7.4K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.